SMOFLIPID 20% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Smoflipid 20%, and what generic alternatives are available?
Smoflipid 20% is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in SMOFLIPID 20% is fish oil; medium chain triglycerides; olive oil; soybean oil. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fish oil; medium chain triglycerides; olive oil; soybean oil profile page.
Summary for SMOFLIPID 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 19 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SMOFLIPID 20% at DailyMed |
Recent Clinical Trials for SMOFLIPID 20%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | N/A |
| Assiut University | Phase 3 |
| Giulia Manzini | Phase 3 |
